Skip to content

Wholegrain Cereal Diet and Insulin Sensitivity

Effect of Whole Grain Rich Diet on Insulin Sensitivity in Individuals With Metabolic Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00945854
Enrollment
60
Registered
2009-07-24
Start date
2008-03-31
Completion date
2010-12-31
Last updated
2014-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

wholegrain cereals, glycemic index, metabolic syndrome, insulin sensitivity

Brief summary

A diet with the multiple beneficial characteristics of whole grains and, more in general, of healthy cereals favorably influences glucose and insulin metabolism in subjects with metabolic syndrome. Therefore, the aim of the study is to evaluate the long term effects of a diet containing healthy cereals versus a control diet, on glucose and insulin metabolism in subjects with metabolic syndrome.

Interventions

OTHERWholegrain cereal diet

Thirty subjects with metabolic syndrome, after an initial run-in period of 4 weeks, during which they stabilise their own diet and other lifestyle habits, are assigned to a diet based on wholegrain cereals and foods with low glycemic index for a period of 12 weeks. Before and after the dietary treatment, a frequently samples intravenous glucose tolerance is carried out to measure the effects of the intervention on glucose and insulin metabolism. At beginning and at the end of intervention, the subjects consume also a standard test meal to evaluate the postprandial response of glucose, insulin, lipids, oxidative parameters and inflammatory molecules.

OTHERRefined cereal diet

Thirty subjects with metabolic syndrome, after an initial run-in period of 4 weeks, during which they stabilise their own diet and other lifestyle habits, are assigned to a diet based on refined cereals and foods with high glycemic index for a period of 12 weeks. Before and after the dietary treatment, a frequently samples intravenous glucose tolerance is carried out to measure the effects of the intervention on glucose and insulin metabolism. At beginning and at the end of intervention, the subjects consume also a standard test meal to evaluate the postprandial response of glucose, insulin, lipids, oxidative parameters and inflammatory molecules.

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Subjects with at least three of the following criteria of metabolic syndrome according to ATPIII-NCEP criteria: 1. waist circumference \>102 for men and 88 for women, 2. fasting total serum triacyglycerol concentration \>1.7 mmol/L, 3. fasting HDL cholesterol \<1.0 mmol/L for men or \<1.3 mmol/L for women, 4. IFG (plasma glucose between 6.1 and 6.9 mmol/L) or 5. blood pressure \>130/85 mmHg or use of blood pressure medication * Hypertension in stable control (BP \<135/80 mmHg) by means of drugs, which will not be allowed to be changed during the study * Absence of main cardiovascular events (IMA, Ictus)

Exclusion criteria

* Diabetes mellitus diagnosed according to history of diabetes or blood glucose ≥ 200 mg/dL (11.1 mmol/L) 2 hours after a 75 g Oral glucose tolerance test (OGTT) to be performed during the run-in period in all the subjects * Any drug able to influence glucose and lipid metabolism (hypolipidemic drugs, cholesterol lowering foodstuffs, anti-inflammatory drugs) * Renal failure (serum creatinine \> 1.5 mg/dL) and liver failure (ALT/AST\> 2 times above normal values) * Anemia (Hb \< 12g/dl) or any other chronic disease

Design outcomes

Primary

MeasureTime frameDescription
Insulin Sensitivity (Si)12 weeksPeripheral insulin sensitivity was assessed by FSIGT. A glucose dose of 300 mg/kg body weight was given intravenously followed by a bolus of 0.03 U/kg of insulin injected after 20 min. Blood samples were frequently collected for 3 h for the measurement of plasma glucose and serum insulin concentrations, utilized to calculate the insulin sensitivity index Si

Secondary

MeasureTime frameDescription
Postprandial Insulin Changes12 weeksBlood samples during the standard meal test were drawn from an antecubital vein after a 12 h overnight fast and 0, 30, 60, 90, 120, 150 and 180 min postprandial for the measurement of plasma insulin response reported as average mean postprandial increment.
Postprandial Plasma Lipid Changes12 weeksBlood samples during the standard meal test were drawn from an antecubital vein after a 12 h overnight fast and 0, 30, 60, 90, 120, 150 and 180 min postprandial for the measurement of triglyceride response reported as average mean postprandial increment.

Countries

Italy

Participant flow

Participants by arm

ArmCount
Wholegrain Cereal Diet
Treatment with a diet based on wholegrain cereals and foods with low glycemic index Wholegrain cereal diet: Thirty subjects with metabolic syndrome, after an initial run-in period of 4 weeks, during which they stabilise their own diet and other lifestyle habits, are assigned to a diet based on wholegrain cereals and foods with low glycemic index for a period of 12 weeks. Before and after the dietary treatment, a frequently samples intravenous glucose tolerance is carried out to measure the effects of the intervention on glucose and insulin metabolism. At beginning and at the end of intervention, the subjects consume also a standard test meal to evaluate the postprandial response of glucose, insulin, lipids, oxidative parameters and inflammatory molecules.
30
Refined Cereal Diet
Treatment with a diet based on refined cereals and foods with high glycemic index Refined cereal diet: Thirty subjects with metabolic syndrome, after an initial run-in period of 4 weeks, during which they stabilise their own diet and other lifestyle habits, are assigned to a diet based on refined cereals and foods with high glycemic index for a period of 12 weeks. Before and after the dietary treatment, a frequently samples intravenous glucose tolerance is carried out to measure the effects of the intervention on glucose and insulin metabolism. At beginning and at the end of intervention, the subjects consume also a standard test meal to evaluate the postprandial response of glucose, insulin, lipids, oxidative parameters and inflammatory molecules.
30
Total60

Baseline characteristics

CharacteristicWholegrain Cereal DietRefined Cereal DietTotal
Age, Continuous57.2 years
STANDARD_DEVIATION 8.5
57.4 years
STANDARD_DEVIATION 7.3
57.2 years
STANDARD_DEVIATION 7.9
Region of Enrollment
Italy
30 participants30 participants60 participants
Sex: Female, Male
Female
17 Participants17 Participants34 Participants
Sex: Female, Male
Male
13 Participants13 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Insulin Sensitivity (Si)

Peripheral insulin sensitivity was assessed by FSIGT. A glucose dose of 300 mg/kg body weight was given intravenously followed by a bolus of 0.03 U/kg of insulin injected after 20 min. Blood samples were frequently collected for 3 h for the measurement of plasma glucose and serum insulin concentrations, utilized to calculate the insulin sensitivity index Si

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Wholegrain Cereal DietInsulin Sensitivity (Si)3.03 104xmin-1/microU/mlStandard Error 0.16
Refined Cereal DietInsulin Sensitivity (Si)3.15 104xmin-1/microU/mlStandard Error 0.19
p-value: <0.05ANCOVA
Secondary

Postprandial Insulin Changes

Blood samples during the standard meal test were drawn from an antecubital vein after a 12 h overnight fast and 0, 30, 60, 90, 120, 150 and 180 min postprandial for the measurement of plasma insulin response reported as average mean postprandial increment.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Wholegrain Cereal DietPostprandial Insulin Changes50.01 (microU/mlx3hrs)Standard Deviation 10.2
Refined Cereal DietPostprandial Insulin Changes64.4 (microU/mlx3hrs)Standard Deviation 12.4
Secondary

Postprandial Plasma Lipid Changes

Blood samples during the standard meal test were drawn from an antecubital vein after a 12 h overnight fast and 0, 30, 60, 90, 120, 150 and 180 min postprandial for the measurement of triglyceride response reported as average mean postprandial increment.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Wholegrain Cereal DietPostprandial Plasma Lipid Changes22.7 mg/dlx3hrsStandard Deviation 4.2
Refined Cereal DietPostprandial Plasma Lipid Changes47.6 mg/dlx3hrsStandard Deviation 6.8

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026